144 related articles for article (PubMed ID: 26487385)
1. [Position on blood collection and use of convalescent plasma as a treatment option in the outbreak of severe infections].
Mitteilungen des Arbeitskreises Blut des Bundesministeriums für Gesundheit
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1371-7. PubMed ID: 26487385
[No Abstract] [Full Text] [Related]
2. Infectious diseases. Ebola survivors fight back in plasma studies.
Enserink M
Science; 2015 May; 348(6236):742-3. PubMed ID: 25977529
[No Abstract] [Full Text] [Related]
3. Treatment of Ebola virus infection with antibodies from reconvalescent donors.
Kreil TR
Emerg Infect Dis; 2015 Mar; 21(3):521-3. PubMed ID: 25695274
[TBL] [Abstract][Full Text] [Related]
4. Treatment-donation-stockpile dynamics in ebola convalescent blood transfusion therapy.
Huo X; Sun X; Lan K; Wu J
J Theor Biol; 2016 Mar; 392():53-61. PubMed ID: 26721704
[TBL] [Abstract][Full Text] [Related]
5. Ebola virus convalescent blood products: where we are now and where we may need to go.
Burnouf T; Seghatchian J
Transfus Apher Sci; 2014 Oct; 51(2):120-5. PubMed ID: 25457751
[TBL] [Abstract][Full Text] [Related]
6. [Determining donor eligibility and donor suitability of hemochromatosis marker carriers ].
Mitteilungen des Arbeitskreises Blut des Bundesministeriums für Gesundheit
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1349-50. PubMed ID: 26487383
[No Abstract] [Full Text] [Related]
7. Managing Ebola: Lessons Learned from the SARS Epidemic.
Nanji KC; Orser BA
Anesth Analg; 2015 Sep; 121(3):834-835. PubMed ID: 26287305
[No Abstract] [Full Text] [Related]
8. Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies.
Geisen C; Kann G; Strecker T; Wolf T; Schüttfort G; van Kraaij M; MacLennan S; Rummler S; Weinigel C; Eickmann M; Fehling SK; Krähling V; Seidl C; Seifried E; Schmidt M; Schäfer R
Vox Sang; 2016 May; 110(4):329-35. PubMed ID: 26766162
[TBL] [Abstract][Full Text] [Related]
9. The ongoing evolution of antibody-based treatments for Ebola virus infection.
Mendoza EJ; Racine T; Kobinger GP
Immunotherapy; 2017 Mar; 9(5):435-450. PubMed ID: 28357917
[TBL] [Abstract][Full Text] [Related]
10. Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak.
Edwards T; Semple MG; De Weggheleire A; Claeys Y; De Crop M; Menten J; Ravinetto R; Temmerman S; Lynen L; Bah EI; Smith PG; van Griensven J;
Clin Trials; 2016 Feb; 13(1):13-21. PubMed ID: 26768570
[TBL] [Abstract][Full Text] [Related]
11. Use of convalescent plasma in Ebola virus infection.
Garraud O
Transfus Apher Sci; 2017 Feb; 56(1):31-34. PubMed ID: 28094110
[TBL] [Abstract][Full Text] [Related]
12. The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States.
Kraft CS; Hewlett AL; Koepsell S; Winkler AM; Kratochvil CJ; Larson L; Varkey JB; Mehta AK; Lyon GM; Friedman-Moraco RJ; Marconi VC; Hill CE; Sullivan JN; Johnson DW; Lisco SJ; Mulligan MJ; Uyeki TM; McElroy AK; Sealy T; Campbell S; Spiropoulou C; Ströher U; Crozier I; Sacra R; Connor MJ; Sueblinvong V; Franch HA; Smith PW; Ribner BS;
Clin Infect Dis; 2015 Aug; 61(4):496-502. PubMed ID: 25904375
[TBL] [Abstract][Full Text] [Related]
13. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak.
Bornholdt ZA; Turner HL; Murin CD; Li W; Sok D; Souders CA; Piper AE; Goff A; Shamblin JD; Wollen SE; Sprague TR; Fusco ML; Pommert KB; Cavacini LA; Smith HL; Klempner M; Reimann KA; Krauland E; Gerngross TU; Wittrup KD; Saphire EO; Burton DR; Glass PJ; Ward AB; Walker LM
Science; 2016 Mar; 351(6277):1078-83. PubMed ID: 26912366
[TBL] [Abstract][Full Text] [Related]
14. Largest-ever outbreak of Ebola virus disease thrusts experimental therapies, vaccines into spotlight.
Hampton T
JAMA; 2014 Sep; 312(10):987-9. PubMed ID: 25162140
[No Abstract] [Full Text] [Related]
15. Treatment of severe acute respiratory syndrome with convalescent plasma.
Wong VW; Dai D; Wu AK; Sung JJ
Hong Kong Med J; 2003 Jun; 9(3):199-201. PubMed ID: 12777656
[TBL] [Abstract][Full Text] [Related]
16. Do therapeutic antibodies hold the key to an effective treatment for Ebola hemorrhagic fever?
Takada A
Immunotherapy; 2013 May; 5(5):441-3. PubMed ID: 23638738
[No Abstract] [Full Text] [Related]
17. Convalescent plasma: new evidence for an old therapeutic tool?
Marano G; Vaglio S; Pupella S; Facco G; Catalano L; Liumbruno GM; Grazzini G
Blood Transfus; 2016 Mar; 14(2):152-7. PubMed ID: 26674811
[TBL] [Abstract][Full Text] [Related]
18. Apheresis for collection of Ebola convalescent plasma in Liberia.
Brown JF; Rowe K; Zacharias P; van Hasselt J; Dye JM; Wohl DA; Fischer WA; Cunningham CK; Thielman NM; Hoover DL
J Clin Apher; 2017 Jun; 32(3):175-181. PubMed ID: 27393614
[TBL] [Abstract][Full Text] [Related]
19. Compassionate use of experimental drugs in the Ebola outbreak.
Folayan M; Brown B; Yakubu A; Peterson K; Haire B
Lancet; 2014 Nov; 384(9957):1843-1844. PubMed ID: 25220192
[No Abstract] [Full Text] [Related]
20. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee.
Mupapa K; Massamba M; Kibadi K; Kuvula K; Bwaka A; Kipasa M; Colebunders R; Muyembe-Tamfum JJ
J Infect Dis; 1999 Feb; 179 Suppl 1():S18-23. PubMed ID: 9988160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
